Campbell & CO Investment Adviser LLC Increases Stock Position in Encompass Health Corporation $EHC

Campbell & CO Investment Adviser LLC boosted its position in shares of Encompass Health Corporation (NYSE:EHC) by 16.1% in the second quarter, Holdings Channel.com reports. The firm owned 23,437 shares of the company’s stock after acquiring an additional 3,246 shares during the period. Campbell & CO Investment Adviser LLC’s holdings in Encompass Health were worth $2,874,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in EHC. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Encompass Health during the second quarter valued at about $306,000. Parkside Financial Bank & Trust grew its stake in Encompass Health by 179.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 478 shares of the company’s stock valued at $59,000 after purchasing an additional 307 shares in the last quarter. Savant Capital LLC increased its holdings in Encompass Health by 7.4% during the 2nd quarter. Savant Capital LLC now owns 3,121 shares of the company’s stock worth $383,000 after purchasing an additional 214 shares during the last quarter. Trillium Asset Management LLC raised its position in shares of Encompass Health by 27.7% in the 2nd quarter. Trillium Asset Management LLC now owns 205,323 shares of the company’s stock valued at $25,179,000 after purchasing an additional 44,490 shares in the last quarter. Finally, Machina Capital S.A.S. purchased a new position in shares of Encompass Health during the 2nd quarter valued at approximately $415,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Price Performance

EHC opened at $115.18 on Monday. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. The company’s 50-day moving average price is $123.54 and its 200 day moving average price is $119.64. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $127.99. The firm has a market cap of $11.59 billion, a price-to-earnings ratio of 21.77, a price-to-earnings-growth ratio of 2.20 and a beta of 0.91.

Encompass Health (NYSE:EHC) last posted its earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. The company had revenue of $136.30 million during the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. As a group, sell-side analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Friday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is presently 14.37%.

Wall Street Analyst Weigh In

EHC has been the subject of a number of research analyst reports. UBS Group lifted their price target on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Thursday, October 2nd. Raymond James Financial raised shares of Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. KeyCorp upped their target price on shares of Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a research note on Tuesday, September 16th. Truist Financial lifted their price target on Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a research note on Thursday, August 14th. Finally, Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. Three equities research analysts have rated the stock with a Strong Buy rating and eight have issued a Buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $142.86.

Insider Activity

In other news, EVP Patrick William Tuer sold 1,020 shares of the company’s stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the transaction, the executive vice president owned 18,846 shares in the company, valued at approximately $2,329,177.14. This represents a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 2.00% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.